BSE filing, NSE: SUNTECHNO. Summary written from the filing by ALFA Finder's alert engine.
Biogen Pharmachem Industries Ltd: key numbers
- Share price
- ₹0.25
- Market cap
- ₹26.33 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.86 Cr
- P/E (TTM)
- -158.2×Sector 19.7×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biogen Pharmachem Industries Ltd
All →Biogen Pharmachem Industries Board Meeting Date
Biogen Pharmachem Industries Ltd intimated a board meeting on 3 November 2026 to approve unaudited results for Q2 and half year ended 30 September 2026. The filing is a meeting notice only, with no monetary event.
Biogen Pharmachem Industries Capital Structure Change
Rama Shiva Lease Finance disposed of all 4.26 crore Biogen Pharmachem shares in open market. The non-promoter now holds zero stake, fully exiting the company.
Biogen Pharmachem Industries Annual General Meeting
Biogen Pharmachem Industries Limited held its 31st Annual General Meeting on 29th September 2026. Shareholders approved financial statements, director re-appointment, and the auditor appointment.
Biogen Pharmachem Industries Annual Report
Biogen Pharmachem Industries Limited submitted its 31st Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 29, 2026.
Biogen Pharmachem Industries Annual General Meeting
Biogen Pharmachem Industries Ltd has issued a notice for its 31st Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Biogen Pharmachem Industries Other Announcement
Biogen Pharmachem Industries Limited has reported no unutilised funds from any prior capital raises, including public issues, rights issues, or preferential allotments, as of June 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.